Cashu
Pulse Biosciences: Leading Innovations in Bioelectric Therapy and Anticipating Earnings Growth
3 months ago
Stocks
Health Care
plse
Pulse Biosciences
NASDAQ: PLSE
+7.04 (+51.46%)
20.735
USD
At close at Feb 06, 21:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
921.04M
Dividend Yield
0.00%
P/E Ratio
-12.32
EPS
-0.91
Revenue
-
Avg. Volume
247.32K
About
What does PLSE do?
Pulse Biosciences, based in Hayward, California, develops proprietary oncolytic electroceutical therapies using Nano Pulse Stimulation (NPS) technology for various medical applications. The company went public on May 18, 2016, and employs 56 staff.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.